Life Sciences Tools and Services(IN00319.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Life Sciences Tools and Services
IN00319.US
News
View More

10:30 ET Drug Discovery Technologies Market worth $51.51 billion by 2031 | MarketsandMarkets™

The Drug Discovery Technologies Market is projected to grow from USD 30.58 billion in 2025 to USD 51.51 billion by 2030, at a CAGR of 11.0%. Key segments include reagents & consumables, high-throughput screening, and oncology, with North America leading the market. Advancements in automation, AI, and integrated workflows are enhancing drug development processes. Major companies in this sector include Thermo Fisher Scientific, Danaher, and Illumina. The market is driven by increased research initiatives and funding in cancer treatment and drug discovery technologies.

prnewswire·
US
DHR
+0.41%
US
TMO
+0.46%
prnewswire·
US
DHR
+0.41%
US
TMO
+0.46%

Waters Corporation Earnings Preview: What to Expect

Waters Corporation Earnings Preview: What to Expect

Barchart Option·
US
WAT
+0.26%
Barchart Option·
US
WAT
+0.26%

Earnings Preview: What to Expect From West Pharmaceutical Services' Report

Earnings Preview: What to Expect From West Pharmaceutical Services' Report

Barchart Option·
US
WST
+1.52%
Barchart Option·
US
WST
+1.52%

Conning Inc. Has $5.31 Million Stake in Thermo Fisher Scientific Inc. $TMO

Conning Inc. has reduced its stake in Thermo Fisher Scientific Inc. by 16.7%, now holding 10,937 shares valued at approximately $5.31 million. Other institutional investors have also adjusted their holdings, with TIAA Trust National Association increasing its stake by 10.5%. Thermo Fisher's stock recently rose 2.3%, trading at $620.97, and the company reported a quarterly EPS of $5.79, exceeding estimates. Additionally, Thermo Fisher announced a $5 billion share repurchase plan and a quarterly dividend of $0.43 per share, reflecting confidence in its stock value.

Market Beat·
US
TMO
+0.46%
Market Beat·
US
TMO
+0.46%

1,855 Shares in Medpace Holdings, Inc. $MEDP Acquired by Blalock Williams LLC

Blalock Williams LLC acquired 1,855 shares of Medpace Holdings, Inc. (NASDAQ:MEDP) valued at approximately $954,000, making it the 29th largest position in their portfolio. Other institutional investors have also increased their stakes in Medpace. Recent insider sales included VP Susan E. Burwig selling 20,000 shares and CFO Kevin M. Brady selling 3,000 shares. Analysts have mixed ratings on Medpace, with a consensus rating of "Reduce" and an average target price of $491.27. Medpace's stock opened at $616.45, with a market cap of $17.36 billion and a P/E ratio of 43.11.

Market Beat·
US
MEDP
-0.61%
Market Beat·
US
MEDP
-0.61%
Posts
View More

No green to red stops hit while I was away from the screens. Never leave your wing man. I put hard stops in the machine. $Chewy(CHWY.US) $Palo Alto Networks(PANW.US) $Tempus AI(TEM.US) $Qualcomm(QCO......

© 2026 Longbridge｜Disclaimer